ABSTRACT
INTRODUCTION
Congenital heart defects (CHD) are the most common forms of congenital disorders and a significant cause of perinatal mortality. According to the EUROCAT registry, CHD occur in about 0.76% of live births and 0.61% when excluding underlying genetic diseases. However, some studies report an incidence of up to 1.5%, particularly when all cases of intrauterine fetal death (IUFD), termination of pregnancy (TOP) and stillbirth are included [1] [2] [3] . Including early spontaneous miscarriages would allow the calculation of an incidence of CHD close to 'reality', but these cases are nearly impossible to record.
Chromosomal anomalies (particularly Down, Edwards, Patau, Turner and Di George syndromes) and genetic mutations are responsible for less than 15% of CHD and, in most cases, the etiology of CHD remains unknown. Hence, it is critical to assess potential new risk factors for CHD in order to improve detection rate and possibly outcome in affected cases.
Previous studies assessing the risk of CHD in pregnancies conceived after in-vitro fertilization (IVF)/ intracytoplasmic sperm injection (ICSI) showed a slightly higher risk in this group as compared with spontaneous conceptions [4] [5] [6] [7] [8] . Previous meta-analyses also showed an increased risk of all congenital malformations in IVF/ICSI infants 9-11 without significant risk difference between IVF and ICSI 11, 12 . This may be due to the ART procedure or to several other risk factors such as the underlying cause of infertility or the higher incidence of twin pregnancy associated with ART [13] [14] [15] . There is no consensus in current practice guidelines on whether IVF/ICSI conception is an indication for performing fetal echocardiography [16] [17] [18] [19] [20] [21] [22] . The American Institute of Ultrasound in Medicine, American Society of Echocardiography and American Heart Association (AHA) [20] [21] [22] consider IVF an indication for a detailed cardiac scan, but only the AHA guidelines include IVF or ICSI among maternal indications for fetal echocardiography with recommendation class/level of evidence of IIa/A estimating an absolute risk of 1.1-3.3% among live births 22 . The aim of this systematic review and meta-analysis was to estimate the risk of CHD in pregnancies conceived by IVF/ICSI as compared with those conceived spontaneously.
METHODS

Eligibility criteria
This study was performed following the PRISMA guidelines 23 . Population-or hospital-based cohort and case-control studies reporting data on CHD among infants conceived by IVF/ICSI and infants conceived spontaneously were included. In case-control studies, cases were defined as fetuses/infants with CHD and controls were babies without birth defects or with other malformations not associated with ART. Only full-text articles in the English language were included, while duplicate publications, studies with insufficient data on the control group or with poor methodology, reviews and case reports were excluded. Studies reporting data only on multiple pregnancies or with overlapping data were not considered.
Among the studies included in the systematic review, those chosen for the meta-analysis were required to fulfill the following requirements: (1) cohort study; (2) inclusion of IVF/ICSI pregnancies with exclusion of studies involving other assisted reproductive techniques, particularly ovulation induction (OI) and/or intrauterine insemination (IUI); (3) inclusion of IUFD, stillbirths and TOP; and (4) exclusion of all chromosomal abnormalities.
Search strategy and study selection
A systematic search of pertinent articles was conducted in PubMed/MEDLINE, EMBASE and Scopus databases from inception to September 2017, including extensive search of data from the literature. The search included the following medical subject heading (MeSH) terms alone or in different combinations: 'IVF', 'IVF/ICSI', 'ART pregnancy', 'assisted conception', 'birth defect*', 'congenital heart defects*', 'congenital abnormality*' and 'congenital malformation*'. Additionally, the reference lists of related reviews were manually searched.
Two authors (V.G. and P.C.) reviewed independently all the articles using the predetermined inclusion and exclusion criteria. First, titles and abstracts of identified records were screened, checking for duplicates. Second, the full-text articles were selected by the same investigators ( Figure 1 ). Any discrepancies were resolved by discussion until a consensus was reached between the authors.
In the systematic review data on CHD in pregnancies resulting from other infertility treatments such as OI, IUI, frozen embryo transfer (FET), in-vitro maturation (IVM) and preimplantation genetic screening or diagnosis (PGS/PGD) were not considered when they were presented separately from data of IVF/ICSI; in the meta-analysis only data on IVF/ICSI were included. Chromosomal abnormalities were excluded case by case at the time of manual counting of the congenital abnormalities.
Ascertainment of birth defects was performed after birth (ranging from a few days to 10-15 years of age) in all studies and postmortem in those studies including TOP. The prenatal diagnosis and modality of CHD diagnosis were specified when possible.
Data extraction and presentation
Study characteristics were extracted independently by two authors (V.G. and P.C.) and included the following: first author's name, year of publication, country of origin, study period, study design, age at assessment of malformation or CHD, ART type and controls, sample size of both groups, maternal age, number of singleton and twin fetuses in both groups, and inclusion of TOP, IUFD and stillbirths.
The PRISMA statement was used for reporting the Methods, Results and Discussion sections of the current review 23 . Extracted data from all included articles are shown in Table S1 4, 5, 7, 8, 15, .
Assessment of risk of bias
Risk of publication bias was assessed by the use of funnel plots (data not shown). Quality assessment of studies was performed using the Newcastle-Ottawa Scale (Tables S2 and S3 ) 60 . The domains of assessment included selection, comparability and outcome assessment biases. After assessment of risk of bias, its influence on the effect estimates was evaluated by sensitivity analysis. The following potential biases in the methodology of the studies included in the review were evaluated: different protocols of ART across the large interval of time covered by studies (1996-2017); characteristics and size of the population, such as maternal age and number of multiple pregnancies; and several different types of CHD with variable degrees of severity. Other sources of bias were assessed, such as funding bias and multiple citation bias (different studies with overlapping databases). Therefore, studies that were sufficiently similar to provide a clinically meaningful summary were included in the meta-analysis.
Statistical analysis
Incidence of CHD was calculated pooling events and cases of all cohort studies (incidence of CHD = total number of CHD/total number of individuals).
The meta-analysis was conducted to estimate the pooled odds ratio (OR) with 95% CI using the random-effects model and generic inverse variance method. Statistical heterogeneity among the studies was evaluated by the I 2 value. Publication bias was evaluated with the use of funnel plots, where appropriate.
A sensitivity analysis was performed to assess whether the effect size was dependent on the study type or study quality (high-quality studies) and singleton pregnancies. 'High-quality' studies were defined by a Newcastle-Ottawa scale score greater than or equal to 8.
A secondary meta-analysis on the type of CHD was conducted using data on different CHD subtypes provided by only three studies 7, 51, 59 . We defined two groups: (1) major CHD, which included hypoplastic left heart syndrome (HLHS), transposition of great arteries (TGA), tetralogy of Fallot (TOF), coarctation of the aorta (CoA) and atrioventricular septal defect; and (2) minor CHD in which ventricular septal defects (VSD) and atrial septal defects (ASD) were considered.
Finally, we performed a further secondary metaanalysis considering those studies reporting OR adjusted for potential confounding factors in singletons 37, 38, 43 . When more than one regression model was provided, estimates adjusted for the largest number of confounding variables were considered.
All analyses included in the meta-analysis were performed using Review Manager 5.3 61 . In the qualitative evaluation of CHD subtypes, statistical comparisons among groups were made with a chi-square test, and the difference was considered to be statistically significant when the P value was < 0.05.
RESULTS
Study selection and study characteristics
Forty-one observational studies were included in the systematic review (Table S1 ) 4, 5, 7, 8, 15, . Of these, 35/41 were cohort studies, including nine clinic-based studies, and 6/41 were case-control studies, including two clinic-based studies.
Of the 41 studies included, 32 reported data on CHD in pregnancies resulting from IVF or IVF/ICSI together, and five reported only data on ICSI pregnancies. In five studies, the type of ART was not specified or included also OI and/or IUI 5, 8, 49, 53, 55 . The clinical assessment of cardiac malformations was performed in all studies after birth at different times in live births or postmortem in TOP, and in 14/41 studies also during pregnancy. Six studies specified that CHD diagnosis was confirmed by a pediatric cardiologist 5, 7, 48, 53, 55, 56 . Only live births were included in 16/40 of the studies, in 11/40 studies live births and IUFDs and/or stillbirths were considered and in 13/40 of the studies both IUFDs and stillbirths were taken into account together with live births. Votava-Smith and colleagues 56 did not report the outcome of pregnancies studied.
Case-control studies: descriptive analysis
Gutarra-Vilchez and colleagues 36 performed a retrospective population-based case-control study in which cases were newborns or fetuses following TOP with at least one major birth defect and controls were a random sample of babies without birth defects. The exposure factor studied in both populations was ART. They reported 310/2911 (10.6%) cases of CHD in the natural conception group and 40/161 (24.8%) CHD in the ART group and, specifically, 28/83 (33.7%) in the IVF/ICSI group. The association between IVF/ICSI and CHD was significant in both crude and adjusted analyses for confounding factors such as advanced maternal age, parity, pre-existing diabetes, obesity, maternal infection and fetal gender (OR, 4.27; 95% CI, 2.67-6.83; P < 0.001; adjusted OR, 2.83; 95% CI, 1.57-5.08; P < 0.05).
In the study conducted by Reefhuis et al. 4 , mothers of fetuses or newborns with a major birth defect (case group) and mothers of infants without birth defects (control group) were included and mode of conception was analyzed. ART techniques that included IVF, ICSI and zygote/gamete intrafallopian transfer were significantly associated in singletons with septal heart defects, in particular ASD secundum or not otherwise specified (OR, 3.4; 95% CI, 1.8-6.2) and VSD plus ASD (OR, 5.4; 95% CI, 2.1-12.5). These results were observed also after adjusting for maternal age, study center, parity, family income and prematurity.
On the contrary, Schofield et al. 53 did not show a significant association between ART and CHD (singleton only: OR, 1.15; 95% CI, 0.4-3.0), although children with CHD were conceived more frequently by ART (24/410, 5.9% in case group; 20/408, 4.9% in control group; P = 0.54). Data were collected in a referral pediatric cardiac hospital.
Tararbit et al. 5, 55 published two case-control studies on the risk of CHD after ART using data of the Paris Registry of Congenital Malformations from which they selected cases that were fetuses/infants affected by CHD and controls that were fetuses/infants with isolated malformations not associated with ART (clubfoot, angioma, skin abnormality, polydactyly, syndactyly or congenital hip dislocation). ART was associated with CHD after adjusting for maternal age, socioeconomic factors and year of birth in infants without chromosomal abnormalities (adjusted OR, 1.4; 95% CI, 1.1-1.7). The risk was higher for IVF and ICSI than for only OI; moreover, IVF/ICSI techniques were associated with malformation of the outflow tracts and ventriculoarterial connections (adjusted OR, 1.7; 95% CI, 1.1-2.8), conotruncal CHD and double outlet right ventricle (adjusted OR, 1.8; 95% CI, 1.0-3.3) and slightly less with VSD (adjusted OR, 1.4; 95% CI, 0.9-2.0) 5 . Finally, considering only HLHS, TGA, TOF and CoA in live births, stillbirths and TOP, they confirmed the association between ART and TOF (adjusted OR, 2.6; 95% CI, 1.6-4.2) with the greater risk in pregnancy conceived by ICSI (adjusted OR, 3.0; 95% CI, 1.0-8.9) 55 .
Among fetuses that underwent an echocardiogram at a tertiary referral center, 619/2761 (22.4%) had a diagnosis of CHD (case group) and 2142/2761 (77.6%) had normal cardiac structure (control group). Studying the mode of conception, there was no association between IVF/ICSI and CHD, also after controlling for maternal age and multiple gestation (OR, 1.1; 95% CI, 0.77-1.7; P = 0.51) 56 .
Cohort studies
Overall incidence
In all cohort studies, CHD incidence was calculated including only IVF and/or ICSI infants, except in the studies by Davies et al. 8 and Parazzini et al. 49 who reported data on all ART techniques. CHD occurred in 1.21% (2719/224 145) of the IVF/ICSI group and in 0.49% (67 554/13 863 410) of the spontaneous conception group (Table S4) .
Meta-analysis
Eight studies 7, 37, 38, 43, 47, 48, 51, 59 fulfilled the inclusion criteria and were included in the meta-analysis. Among those that included TOP, IUFD and stillbirths, Davies et al. 8 was excluded because they also considered ART techniques other than IVF/ICSI (Table S1) .
Overall, 25 856 fetuses conceived from IVF/ICSI techniques were compared with 287 995 fetuses conceived spontaneously, both in singleton and multiple pregnancies. The total CHD events were 337/25 856 (1.30%) and 1952/287 995 (0.68%) in the IVF/ICSI and spontaneous conception groups, respectively (Figure 2 Test for overall effect: Z = 3.63 (P = 0.0003) Figure 3 Forest plot for congenital heart defects in all in-vitro fertilization/intracytoplasmic sperm injection (IVF) pregnancies and in all pregnancies conceived spontaneously (SC) obtained by only high-quality studies (sensitivity analysis). Only first author of each study is given.
a significantly increased risk of CHD was observed (OR, 1.45; 95% CI, 1.20-1.76; P = 0.0001; I 2 = 44%; P = 0.08).
Sensitivity analysis that included seven high-quality studies 7, 37, 38, 43, 48, 51, 59 showed that the risk of CHD in fetuses conceived after IVF/ICSI was significantly higher than in those conceived naturally, irrespective of the study quality (OR, 1.45; 95% CI, 1.19-1.77; P = 0.0003; I 2 = 52%; P = 0.05) (Figure 3) .
In the secondary analysis based on the few available data on specific types of CHD (Figure 4) , the slightly increased risk of all cardiac malformations after IVF/ICSI was not significant (OR, 1.13; 95% CI, 0.68-1.86; P = 0.33, I 2 = 38%; P = 0.16) and seemed to be related to minor CHD (OR, 1.30; 95% CI, 0.66-2.56; P = 0.45; I 2 = 54%; P = 0.11) rather than major CHD (OR, 0.62; 95% CI, 0.16-2.39; P = 0.49; I 2 = 33%; P = 0.22). Considering only children born from singleton pregnancies 37, 38, 43, 48, 51 , CHD was higher in the IVF/ICSI group than in infants conceived naturally with lower heterogeneity among the two groups (OR, 1.55; 95% CI, 1.21-1.99; P = 0.0005; I 2 = 36%; P = 0.18) ( Figure 5 ). When considering three studies that reported the adjusted ORs for maternal age and parity in singletons 37, 38, 43 , the meta-analysis showed also an increased risk of CHD among IVF/ICSI pregnancies compared with controls (pooled OR, 1.29; 95% CI, 1.03-1.60; P = 0.02) with no heterogeneity (I 2 = 0%, P = 0.43) (Figure 6 ). Figure 7 and Table 1 show the qualitative distribution between IVF/ICSI and control groups of a specific type of CHD reported in four studies in which both live births and TOP were considered 4, 7, 51, 59 . Minor CHD-like VSD and ASD, as well as HLHS were more frequent in IVF/ICSI pregnancies than in controls, whereas TOF, TGA and CoA were less frequent in the IVF/ICSI group as compared with the spontaneous conception group 
Qualitative evaluation of CHD subtypes in cohort and case-control studies
Minor CHD
Test for subgroup differences: chi 2 = 0.93, df = 1 (P = 0.33); I 2 = 0% Figure 4 Forest plot for major congenital heart defects (CHD) and minor CHD in in-vitro fertilization/intracytoplasmic sperm injection (IVF) pregnancies and in pregnancies conceived spontaneously (SC). Only first author of each study is given. Major CHD included tetralogy of Fallot, transposition of great arteries, hypoplastic left heart syndrome, coarctation of aorta and atrioventricular septal defect; minor CHD included ventricular septal defect and atrial septal defect.
Halliday (2010) Total (95% CI) Total events Heterogeneity: tau 2 = 0.03; chi 2 = 6.24, df = 4 (P = 0.18); I 2 = 36% Test for overall effect: Z = 3.46 (P = 0.0005) Figure 5 Forest plot for congenital heart defects in singleton in-vitro fertilization/intracytoplasmic sperm injection (IVF) pregnancies and in singleton pregnancies conceived spontaneously (SC). Only first author of each study is given.
(unadjusted data). However, the divergent distribution of CHD subtypes among the two groups was significant only for TOF, TGA and VSD.
DISCUSSION
Summary of evidence
The risk of CHD in IVF/ICSI pregnancies is significantly increased by about 50% as compared with pregnancies conceived spontaneously, with stable significance in most subgroup analyses. In particular a subgroup analysis of three studies adjusted for maternal age, parity and other confounding factors maintained statistical significance 37, 38, 43 .
Interpretation
Previous meta-analyses showed increased risk of birth defects 9,10 and cardiovascular defects 11 in IVF/ICSI pregnancies. The rate of TOP for prenatally diagnosed CHD (without chromosomal anomalies) is 30-50%, and this is often related to disease severity and maternal geographic origin 62 . TOP reduces the incidence of CHD Halliday (2010) 37 
Study or subgroup Weight
Odds ratio IV, random, 95% CI Odds ratio IV, random, 95% CI log(odds ratio) SE Hansen (2012) 38 Klemetti (2005) Total (95% CI) Heterogeneity: tau 2 = 0.00; chi 2 = 1.70, df = 2 (P = 0.43); I 2 = 0% Test for overall effect: Z = 2.24 (P = 0.02) 2 0.2
Figure 6
Forest plot for congenital heart defects in singleton in-vitro fertilization/intracytoplasmic sperm injection (IVF) pregnancies and in singleton pregnancies conceived spontaneously (SC) obtained considering only studies with adjusted odds ratios for maternal age and other factors. Only first author of each study is given. IV, inverse variance; SE, standard error. Distribution of different types of congenital heart defects between pregnancies conceived by in-vitro fertilization/intracytoplasmic sperm injection (IVF, ) and those conceived spontaneously (SC, ). Total number of congenital heart defects is 353 for IVF group and 9526 for SC group. ASD, atrial septal defect; CoA, coarctation of aorta; HLHS, hypoplastic left heart syndrome; TGA, transposition of great arteries; TOF, tetralogy of Fallot; VSD, ventricular septal defect. by about 20% and particularly that of major defects 63 . It is unclear whether mode of conception can influence the decision of ART couples towards interruption of their 'precious' pregnancies, in cases of CHD 64 . To overcome this potential bias, the meta-analysis was conducted considering only studies in which the incidence of TOP was well documented. Prenatal surveillance may also show considerable variations and it is generally believed to be more rigorous in ART than in non-ART pregnancies, with potential increase of detection rate [63] [64] [65] . However, all studies included in the meta-analysis reported similar standard prenatal and postnatal care methodology.
Maternal age has a well-known association with major chromosomal defects associated with CHD 66 , but also represents an independent risk factor for some non-chromosomal CHD 67 . This could explain why, despite exclusion of all chromosomal defects, the odds ratio decreased only slightly after adjustment for maternal age (Figure 6 ). In other studies, the adjustment for maternal age did not modify the association between ART and CHD 5, 8 . However, a recent experiment in the mouse model confirmed such age-related risk for CHD and proposed preventive lifestyle interventions 68 . Older women can have additional risk factors of CHD such as pregestational diabetes, autoimmune disease, infection, drug exposure, poor oocyte quality, uterine aging or other causes of infertility.
Subanalysis excluding twins confirmed the findings of the pooled analysis and that of a previous study 14 . A slight decrease of the overall effect was expected after exclusion of monochorionic twins, but this was not obtained by our analysis, most likely due to the rarity of both monochorionicity and CHD [69] [70] [71] . Qualitative analysis summarizing data collected from four studies concerning types of CHD associated with IVF/ICSI 4, 7, 51, 59 ( Figure 7 and Table 1) showed that VSD were more frequent in IVF/ICSI, whereas TOF and TGA were more common in pregnancies conceived spontaneously. This issue remains unresolved and controversial, being consistent with results reported by Reefhuis et al. 4 and divergent from other studies that showed a specific association between ART and conotruncal defects, in particular TOF 5, 55 . These qualitative data should be evaluated with caution as adjustment for confounding factors is impossible and there is potential selection bias related to different approaches of ART and non-ART patients.
A recent meta-analysis from our group showed that IVF/ICSI pregnancies present placental dysfunction with lower pregnancy-associated plasma protein A (PAPP-A) and higher free β-human chorionic gonadotropin concentrations in the first trimester 72 . Recent data also show that, in pregnancies with isolated major CHD, there is significantly lower PAPP-A and placental growth factor in the absence of impaired placental perfusion and increased risk of pre-eclampsia 73, 74 . Therefore, it is reasonable to hypothesize that IVF/ICSI pregnancies present an increased risk of CHD as a consequence of early placental dysfunction.
Strengths and limitations
Strengths of our study include that it is the first systematic review and meta-analysis focussing on the incidence of CHD in a specific subset of ART pregnancies (IVF/ICSI); it provides evidence suggesting the need for increased fetal surveillance in IVF/ICSI pregnancies with fetal echocardiography, particularly in twins; and it provides preliminary data summarizing type of CHD associated with IVF/ICSI (mainly VSD).
Our study has some limitations. ART pregnancies encompass many different techniques such as OI, IUD, IVF and ICSI and there are several other variables that could affect fetal development and pregnancy outcome, including different drug protocols of ovarian controlled stimulation, methods of gametes and embryonic micromanipulation including cryopreservation and PGS/PGD, transfer of blastocyst vs cleavage stage embryos, sperm retrieval techniques and sperm/egg/embryo donation.
We considered only IVF/ICSI pregnancies in which both sperm and egg are handled medically. The association between ICSI and fetal anomalies is controversial 8, 11, 12 . Subanalysis of IVF vs ICSI was impossible in our study due to paucity of data 38 . Evaluation of cause of infertility was also not possible and this can be associated with congenital malformation, rather than IVF/ICSI treatments 8, 13, 15, 75, 76 . Infertile couples achieving pregnancy naturally after a significant delay (> 12 months or had previous IVF/ICSI treatment) are likely to be the best control group to study the risk of CHD; nevertheless, only a few studies have analyzed this 15, 47, 76 . Moreover, the detection rate of CHD varies due to timing of assessment, expertise of the examiner and methodology used. It is possible that, in the IVF/ICSI group, prenatal surveillance may have been more accurate resulting in a greater detection (and incidence) of CHD.
Finally, CHD is a heterogeneous group of disorders including both severe and life-threatening diseases and minor defects amenable to spontaneous resolution, such as isolated small VSD [77] [78] [79] . Therefore, since malformation assessment was performed across a wide time span in the studies, some types of minor CHD could have been missed in both groups.
Conclusion
This study shows an increased risk of CHD in IVF/ICSI pregnancies as compared with those conceived spontaneously, by about 50%. We recommend fetal echocardiography in all pregnancies from IVF/ICSI in accordance with recent AHA practice guidelines 22 with prompt referral to specialist care in selected cases. This method should improve prenatal diagnosis, management and referral of affected pregnancies for delivery and pre-/postnatal intervention, with potential improvement of outcome 80 . Future studies on ART should investigate further the role of imprinting disorders in CHD (Beckwith-Wiedemann syndrome), stratify for maternal age or ovarian reserve and develop primary prevention study protocols on the association between periconceptional intake of folic acid supplements and the risk of CHD [81] [82] [83] , as on the role of other micronutrients such as the inositol 1,4,5-trisphosphate in cardiogenesis 84 . While research on this topic gets underway, the administration of a high-dose of folic acid supplementation would be desirable in IVF/ICSI patients.
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